EMT and Cancer: More Than Meets the Eye
Open accessAbstract
Epithelial cells acquire mesenchymal characteristics during development, wound healing and inflammation, and in cancer and fibrosis. With increasing appreciation of different roles of epithelial-mesenchymal transition (EMT), we address the question of how to define and recognize EMT processes and discuss their properties in cancer progression.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In multiple carcinoma types, EMT raises the count of cells with cancer stem cell features.
“In a variety of carcinomas, EMT increases the number of carcinoma cells with stem cell properties, i.e. cancer stem cells (CSCs)34,37,127,137.”
From TGFβ biology in cancer progression and immunotherapy (2021) · cites this paper as [127]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Molecular mechanisms of epithelial–mesenchymal transition
Lamouille, S., Xu, J., & Derynck, R. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3758 · Cited by 8,091 · see citing works
Self-citationNieto, M. A., Huang, R. Y.-J., Jackson, R. A., & Thiery, J. P. (2016) · Cell · doi:10.1016/j.cell.2016.06.028 · Cited by 4,492 · see citing works
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
Dongre, A., & Weinberg, R. A. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0080-4 · Cited by 3,876 · see citing works
Self-citationEMT Transition States during Tumor Progression and Metastasis
Pastushenko, I., & Blanpain, C. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.12.001 · Cited by 2,866 · see citing works
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
Shibue, T., & Weinberg, R. A. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.44 · Cited by 2,539 · see citing works
Self-citationSlug and Sox9 Cooperatively Determine the Mammary Stem Cell State
Guo, W., Keckesova, Z., Donaher, J. L., Shibue, T., Tischler, V., Reinhardt, F., Itzkovitz, S., Noske, A., Zürrer‐Härdi, U., Bell, G. W., et al. (2012) · Cell · doi:10.1016/j.cell.2012.02.008 · Cited by 969 · see citing works
Self-citationEMT Subtype Influences Epithelial Plasticity and Mode of Cell Migration
Aiello, N. M., Maddipati, R., Norgard, R. J., Balli, D., Li, J., Yuan, S., Yamazoe, T., Black, T. A., Sahmoud, A., Furth, E. E., et al. (2018) · Developmental Cell · doi:10.1016/j.devcel.2018.05.027 · Cited by 708 · see citing works
Regulation of the Immune Response by TGF-β: From Conception to Autoimmunity and InfectionPreprint
Sanjabi, S., Oh, S. A., & Li, M. O. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022236 · Cited by 626 · see citing works
Non-redundant functions of EMT transcription factors
Stemmler, M. P., Eccles, R. L., Brabletz, S., & Brabletz, T. (2019) · Nature Cell Biology · doi:10.1038/s41556-018-0196-y · Cited by 524 · see citing works
New insights into the role of <scp>EMT</scp> in tumor immune escape
Terry, S., Savagner, P., Ortiz‐Cuaran, S., Mahjoubi, L., Saintigny, P., Thiery, J., & Chouaib, S. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12093 · Cited by 414 · see citing works
Epithelial-to-Mesenchymal Transition Contributes to Immunosuppression in Breast Carcinomas
Dongre, A., Rashidian, M., Reinhardt, F., Bagnato, A., Keckesova, Z., Ploegh, H. L., & Weinberg, R. A. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-3292 · Cited by 395 · see citing works
Self-citationTherapy resistance mediated by cancer stem cells
Steinbichler, T. B., Dudás, J., Skvortsov, S., Ganswindt, U., Riechelmann, H., & Skvortsova, I. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.11.006 · Cited by 289 · see citing works
Katsuno, Y., Meyer, D. S., Zhang, Z., Shokat, K. M., Akhurst, R. J., Miyazono, K., & Derynck, R. (2019) · Science Signaling · doi:10.1126/scisignal.aau8544 · Cited by 219 · see citing works
Self-citationA common framework for EMT and collective cell migration
Campbell, K., & Casanova, J. (2016) · Development · doi:10.1242/dev.139071 · Cited by 177 · see citing works
Epithelial-mesenchymal transition and senescence: two cancer-related processes are crossing paths
Smit, M. A., & Peeper, D. S. (2010) · Aging · doi:10.18632/aging.100209 · Cited by 104 · see citing works
Pal, D., Pertot, A., Shirole, N. H., Yao, Z., Anaparthy, N., Garvin, T., Cox, H., Chang, K., Rollins, F., Kendall, J., et al. (2017) · eLife · doi:10.7554/elife.21615 · Cited by 41 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis
Huang, Y., Hong, W., & Wei, X. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01347-8 · Cited by 1,065 · see citing works
EMT, MET, Plasticity, and Tumor Metastasis
Bakir, B. S., Chiarella, A. M., Pitarresi, J. R., & Rustgi, A. K. (2020) · Trends in Cell Biology · doi:10.1016/j.tcb.2020.07.003 · Cited by 1,030 · see citing works
TGFβ biology in cancer progression and immunotherapy
Derynck, R., Turley, S. J., & Akhurst, R. J. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0403-1 · Cited by 944 · see citing works
Self-citationFluids and their mechanics in tumour transit: shaping metastasis
Follain, G., Herrmann, D., Harlepp, S., Hyenne, V., Osmani, N., Warren, S. C., Timpson, P., & Goetz, J. G. (2019) · Nature reviews. Cancer · doi:10.1038/s41568-019-0221-x · Cited by 413 · see citing works
Tumour budding in solid cancers
Lugli, A., Zlobec, I., Berger, M. D., Kirsch, R., & Nagtegaal, I. D. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0422-y · Cited by 372 · see citing works
Fousek, K., Horn, L. A., & Palena, C. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107692 · Cited by 361 · see citing works
EMT Factors and Metabolic Pathways in Cancer
Georgakopoulos‐Soares, I., Chartoumpekis, D. V., Kyriazopoulou, V. E., & Zaravinos, A. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00499 · Cited by 348 · see citing works
Inflammation-Induced Tumorigenesis and Metastasis
Hibino, S., Kawazoe, T., Kasahara, H., Itoh, S., Ishimoto, T., Sakata‐Yanagimoto, M., & Taniguchi, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115421 · Cited by 303 · see citing works
TGFβ-induced metabolic reprogramming during epithelial-to-mesenchymal transition in cancer
Hua, W., ten Dijke, P., Kostidis, S., Giera, M. A., & Hornsveld, M. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03398-6 · Cited by 237 · see citing works
Context specificity of the EMT transcriptional response
Cook, D. P., & Vanderhyden, B. C. (2020) · Nature Communications · doi:10.1038/s41467-020-16066-2 · Cited by 231 · see citing works
Epithelial to Mesenchymal Transition: A Mechanism that Fuels Cancer Radio/Chemoresistance
Dudás, J., Ladányi, A., Ingruber, J., Steinbichler, T. B., & Riechelmann, H. (2020) · Cells · doi:10.3390/cells9020428 · Cited by 213 · see citing works
Bulle, A. S., & Lim, K. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00341-1 · Cited by 203 · see citing works
Mitchel, J. A., Das, A., O’Sullivan, M. J., Stancil, I. T., DeCamp, S. J., Koehler, S. A., Ocaña, O. H., Butler, J. P., Fredberg, J. J., Nieto, M. A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18841-7 · Cited by 190 · see citing works
Epithelial plasticity, epithelial-mesenchymal transition, and the TGF-β family
Katsuno, Y., & Derynck, R. (2021) · Developmental Cell · doi:10.1016/j.devcel.2021.02.028 · Cited by 187 · see citing works
Self-citationDatta, A., Deng, S., Gopal, V., Yap, K. C.-H., Halim, C. E., Lye, M. L., Ong, M. S., Tan, T. Z., Sethi, G., Hooi, S. C., et al. (2021) · Cancers · doi:10.3390/cancers13081882 · Cited by 184 · see citing works
Progress of exosomes in the diagnosis and treatment of lung cancer
Xu, K., Zhang, C., Du, T., Gabriel, A. N. A., Wang, X., Li, X., Sun, L. J., Wang, N., Jiang, X., & Zhang, Y. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111111 · Cited by 178 · see citing works
TGF-β, EMT, and resistance to anti-cancer treatment
Wang, X., Eichhorn, P. J. A., & Thiery, J. P. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.10.004 · Cited by 180 · see citing works
A Perspective on the Development of TGF-β Inhibitors for Cancer Treatment
Huynh, L., Hipolito, C. J., & ten Dijke, P. (2019) · Biomolecules · doi:10.3390/biom9110743 · Cited by 172 · see citing works
Regulation of breast cancer metastasis signaling by miRNAs
Petri, B. J., & Klinge, C. M. (2020) · Cancer and Metastasis Reviews · doi:10.1007/s10555-020-09905-7 · Cited by 154 · see citing works
Tumor Plasticity and Resistance to Immunotherapy
Horn, L. A., Fousek, K., & Palena, C. (2020) · Trends in cancer · doi:10.1016/j.trecan.2020.02.001 · Cited by 142 · see citing works
Role of Epithelial to Mesenchymal Transition in Colorectal Cancer
Lu, J., Kornmann, M., & Traub, B. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914815 · Cited by 148 · see citing works
Epithelial‐to‐mesenchymal‐like transition events in melanoma
Pedri, D., Karras, P., Landeloos, E., Marine, J., & Rambow, F. (2021) · FEBS Journal · doi:10.1111/febs.16021 · Cited by 126 · see citing works
Ozkan‐Dagliyan, I., Diehl, J. N., George, S. D., Schaefer, A., Papke, B., Klotz‐Noack, K., Waters, A. M., Goodwin, C. M., Gautam, P., Pierobon, M., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107764 · Cited by 102 · see citing works
Role of glycosylation in TGF-β signaling and epithelial-to-mesenchymal transition in cancer
Zhang, J., ten Dijke, P., Wuhrer, M., & Zhang, T. (2020) · Protein & Cell · doi:10.1007/s13238-020-00741-7 · Cited by 99 · see citing works
CircRNA: A novel potential strategy to treat thyroid cancer (Review)
Zhu, G., Chang, X., Kang, Y., Zhao, X., Tang, X., Ma, C., & Fu, S. (2021) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2021.5034 · Cited by 93 · see citing works
Unveiling the link between chronic inflammation and cancer
Tripathi, S., Sharma, Y., & Kumar, D. (2025) · Metabolism Open · doi:10.1016/j.metop.2025.100347 · Cited by 91 · see citing works
Regulation of Collective Metastasis by Nanolumenal Signaling
Wrenn, E. D., Yamamoto, A., Moore, B. M., Huang, Y. C., McBirney, M., Thomas, A. J., Greenwood, E., Rabena, Y., Rahbar, H., Partridge, S. C., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.045 · Cited by 78 · see citing works
Gómez‐Valenzuela, F., Escobar, E., Pérez‐Tomás, R., & Montecinos, V. P. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.686792 · Cited by 77 · see citing works
Epigenetic regulation in lung cancer
Ramazi, S., Dadzadi, M., Sahafnejad, Z., & Allahverdi, A. (2023) · MedComm · doi:10.1002/mco2.401 · Cited by 79 · see citing works
Cofilin: A Promising Protein Implicated in Cancer Metastasis and Apoptosis
Xu, J., Huang, Y., Zhao, J., Wu, L., Qi, Q., Liu, Y., Li, G., Li, J., Liu, H., & Wu, H. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.599065 · Cited by 68 · see citing works
Qin, T., Xiao, Y., Qian, W., Wang, X., Gong, M., Wang, Q., An, R., Han, L., Duan, W., Ma, Q., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04799-5 · Cited by 67 · see citing works
Su, X., Yang, Y., Guo, C., Zhang, R., Sun, S., Wang, Y., Qiao, Q., Fu, Y., & Pang, Q. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/5549047 · Cited by 66 · see citing works
Roles of Notch Signaling in the Tumor Microenvironment
D’Assoro, A. B., Leon-Ferre, R. A., Braune, E.-B., & Lendahl, U. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116241 · Cited by 62 · see citing works
Long non‐coding RNAs and TGF‐β signaling in cancer
Papoutsoglou, P., & Moustakas, A. (2020) · Cancer Science · doi:10.1111/cas.14509 · Cited by 59 · see citing works
Plygawko, A. T., Kan, S., & Campbell, K. (2020) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2020.0087 · Cited by 59 · see citing works
Luo, D., Dai, X., Tian, H., Fan, C., Xie, H.-Y., Chen, N., Wang, J., Huang, L., Wang, H., Wang, H., et al. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154909 · Cited by 58 · see citing works
An, Q., Liu, T., Wang, M., Yang, Y., Zhang, Z., Liu, Z., & Yang, B. L. (2020) · Oncology Reports · doi:10.3892/or.2020.7886 · Cited by 58 · see citing works
Shao, W., Fujiwara, N., Mouri, Y., Kisoda, S., Yoshida, K., Yoshida, K., Yumoto, H., Ozaki, K., Ishimaru, N., & Kudo, Y. (2021) · Scientific Reports · doi:10.1038/s41598-021-94384-1 · Cited by 57 · see citing works
Extracellular Vesicles and Transforming Growth Factor β Signaling in Cancer
Rodrigues‐Junior, D. M., Tsirigoti, C., Lim, S. K., Heldin, C., & Moustakas, A. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.849938 · Cited by 57 · see citing works
Factors Determining Epithelial-Mesenchymal Transition in Cancer Progression
Tomecka, P., Kunachowicz, D., Górczyńska, J., Gebuza, M., Kuźnicki, J., Skinderowicz, K., & Choromańska, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168972 · Cited by 57 · see citing works
ILT3 promotes tumor cell motility and angiogenesis in non-small cell lung cancer
Li, J., Gao, A., Zhang, F., Wang, S., Wang, J., Wang, J., Han, S., Yang, Z., Chen, X., Fang, Y., et al. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.10.048 · Cited by 55 · see citing works
Feng, K.-N., Meng, P., Zou, X., Zhang, M., Li, H., Yang, H., Li, H., & Zhang, T. (2022) · Respiratory Research · doi:10.1186/s12931-022-02167-7 · Cited by 55 · see citing works
Cellular senescence or stemness: hypoxia flips the coin
Otero-Albiol, D., & Carnero, A. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02035-0 · Cited by 53 · see citing works
Fibroblasts as Turned Agents in Cancer Progression
Wieder, R. (2023) · Cancers · doi:10.3390/cancers15072014 · Cited by 54 · see citing works
Karabicici, M., Azbazdar, Y., Özhan, G., Şentürk, Ş., Karagonlar, Z. F., & Erdal, E. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.639779 · Cited by 53 · see citing works
AXL Receptor in Cancer Metastasis and Drug Resistance: When Normal Functions Go Askew
Auyez, A., Sayan, E., Kriajevska, M. V., & Tulchinsky, E. M. (2021) · Cancers · doi:10.3390/cancers13194864 · Cited by 50 · see citing works
Danielpour, D. (2024) · Pharmaceuticals · doi:10.3390/ph17040533 · Cited by 52 · see citing works
EMT and cancer stem cells: Drivers of therapy resistance and promising therapeutic targets
Jiang, M., Wang, J., Li, Y., Zhang, K., Wang, T., Bo, Z., Lu, S., Alarcón, R., Wei, R., Zhu, M., et al. (2025) · Drug Resistance Updates · doi:10.1016/j.drup.2025.101276 · Cited by 56 · see citing works
Mechanical Forces as Determinants of Disseminated Metastatic Cell Fate
Montagner, M., & Dupont, S. (2020) · Cells · doi:10.3390/cells9010250 · Cited by 51 · see citing works
Epithelial to Mesenchymal Transition History: From Embryonic Development to Cancers
Lachat, C., Peixoto, P., & Hervouet, É. (2021) · Biomolecules · doi:10.3390/biom11060782 · Cited by 49 · see citing works
Measuring and Modelling the Epithelial- Mesenchymal Hybrid State in Cancer: Clinical Implications
Jolly, M. K., Murphy, R. J., Bhatia, S., Whitfield, H. J., Redfern, A. D., Davis, M. J., & Thompson, E. W. (2021) · Cells Tissues Organs · doi:10.1159/000515289 · Cited by 48 · see citing works
Basile, D., Broudin, C., Emile, J. F., Falcoz, A., Pagès, F., Mineur, L., Bennouna, J., Louvet, C., Artru, P., Fratte, S., et al. (2022) · Annals of Oncology · doi:10.1016/j.annonc.2022.03.002 · Cited by 47 · see citing works
Targeted therapy for pancreatic ductal adenocarcinoma: Mechanisms and clinical study
Kung, H., & Yu, J. (2023) · MedComm · doi:10.1002/mco2.216 · Cited by 43 · see citing works
Tian, L., Chen, M., He, Q., Yan, Q., & Zhai, C. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11323 · Cited by 45 · see citing works
Autophagy-mediating microRNAs in cancer chemoresistance
Jing, Y., Liang, W., Liu, J., Zhang, L., Wei, J., Yang, J., Zhang, Y., & Huang, Z. (2020) · Cell Biology and Toxicology · doi:10.1007/s10565-020-09553-1 · Cited by 43 · see citing works
The high-grade serous ovarian cancer metastasis and chemoresistance in 3D models
Tadić, V., Zhang, W., & Brozović, A. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.189052 · Cited by 42 · see citing works
Paolillo, M., Colombo, R., Serra, M., Belvisi, L., Papetti, A., Ciusani, E., Comincini, S., & Schinelli, S. (2019) · Cells · doi:10.3390/cells8111434 · Cited by 41 · see citing works
Zhao, L., Liu, Y., Liu, Y., Zhang, M., & Zhang, X. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.0c00408 · Cited by 42 · see citing works
Collective metastasis: coordinating the multicellular voyage
Wrenn, E. D., Huang, Y. C., & Cheung, K. (2021) · Clinical & Experimental Metastasis · doi:10.1007/s10585-021-10111-0 · Cited by 43 · see citing works
Shi, W., Li, Y., Bai, X., & Lin, G. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.834235 · Cited by 41 · see citing works
Sanyal, S., Mondal, P., Sen, S., Sengupta, S., & Das, C. (2020) · Biochemical Journal · doi:10.1042/bcj20200359 · Cited by 40 · see citing works
Zhang, J., van der Zon, G., Ma, J., Mei, H., Cabukusta, B., Agaser, C., Madunić, K., Wuhrer, M., Zhang, T., & ten Dijke, P. (2022) · The EMBO Journal · doi:10.15252/embj.2021110553 · Cited by 39 · see citing works
Abdulla, N., Vincent, C. T., & Kaur, M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.728325 · Cited by 38 · see citing works
Role of Exosomes in Epithelial–Mesenchymal Transition
Bhattacharya, B., Nag, S., Mukherjee, S., Kulkarni, M., Chandane, P., Mandal, D., Mukerjee, N., Mirgh, D., Anand, K., Adhikari, M. D., et al. (2023) · ACS Applied Bio Materials · doi:10.1021/acsabm.3c00941 · Cited by 38 · see citing works
Li, J., Luco, A.-L., Camirand, A., St‐Arnaud, R., & Kremer, R. B. (2021) · Endocrinology · doi:10.1210/endocr/bqab049 · Cited by 36 · see citing works
Emerging roles for HMGA2 in colorectal cancer
Wang, X., Wang, J., & Wu, J. (2020) · Translational Oncology · doi:10.1016/j.tranon.2020.100894 · Cited by 36 · see citing works
FBXO32 links ubiquitination to epigenetic reprograming of melanoma cells
Habel, N., Hachem, N. E., Soysouvanh, F., Bzioueche, H., Giuliano, S., Nguyen, S., Horák, P., Gay, A.-S., Debayle, D., Nottet, N., et al. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-020-00710-x · Cited by 34 · see citing works
Ashrafizadeh, M., Shahinozzaman, M., Orouei, S., Zarrin, V., Hushmandi, K., Hashemi, F., Kumar, A., Samarghandian, S., Najafi, M., & Zarrabi, A. (2021) · Current Cancer Drug Targets · doi:10.2174/1568009621666210203110305 · Cited by 34 · see citing works
Breast cancer circulating tumor cells with mesenchymal features—an unreachable target?
Topa, J., Grešner, P., Zaczek, A. J., & Markiewicz, A. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-04064-6 · Cited by 31 · see citing works
Revisiting the Tenascins: Exploitable as Cancer Targets?
Tucker, R. P., & Degen, M. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.908247 · Cited by 31 · see citing works
Autophagy orchestrates resistance in hepatocellular carcinoma cells
Seydi, H., Nouri, K., Rezaei, N., Tamimi, A., Hassan, M., Mirzaei, H., & Vosough, M. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114487 · Cited by 31 · see citing works
Pawlicka, M., Gumbarewicz, E., Błaszczak, E., & Stepulak, A. (2024) · Cancers · doi:10.3390/cancers16071354 · Cited by 30 · see citing works
Beyond single biomarkers: multi-omics strategies to predict immunotherapy outcomes in blood cancers
Pirouzbakht, M., Hamzeh, S., & Samarkhazan, H. S. (2025) · Clinical and Experimental Medicine · doi:10.1007/s10238-025-01902-w · Cited by 30 · see citing works
AL-Abedi, R., Cagatay, S. T., Mayah, A., Brooks, S. A., & Kadhim, M. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111570 · Cited by 30 · see citing works
YBX1 Enhances Metastasis and Stemness by Transcriptionally Regulating MUC1 in Lung Adenocarcinoma
Xie, Q., Zhao, S., Liu, W., Cui, Y., Li, F., Li, Z., Guo, T., Yu, W., Guo, W., Deng, W., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.702491 · Cited by 30 · see citing works
Potential Therapeutic Applications of N-Cadherin Antagonists and Agonists
Blaschuk, O. W. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.866200 · Cited by 30 · see citing works
Kundu, S. T., Rodriguez, B. L., Gibson, L. A., Warner, A. N., Perez, M. G., Bajaj, R., Fradette, J. J., Class, C. A., Solis, L. M., Alvarez, F. R. R., et al. (2022) · Genes & Development · doi:10.1101/gad.349321.121 · Cited by 30 · see citing works
Vafaizadeh, V., Buechel, D., Rubinstein, N., Kalathur, R. K. R., Bazzani, L., Saxena, M. T., Valenta, T., Hausmann, G., Cantù, C., Basler, K., et al. (2021) · Oncogene · doi:10.1038/s41388-021-02016-9 · Cited by 29 · see citing works
Combinatorial Therapy of Cancer: Possible Advantages of Involving Modulators of Ionic Mechanisms
Djamgoz, M. B. A. (2022) · Cancers · doi:10.3390/cancers14112703 · Cited by 29 · see citing works
Long noncoding RNA Smyca coactivates TGF-β/Smad and Myc pathways to drive tumor progression
Chen, H.-Y., Chan, S.-J., Liu, X., Wei, A., Jian, R.-I., Huang, K., Lang, Y., Shih, J., Liao, C.-C., Luan, C.-L., et al. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01306-3 · Cited by 29 · see citing works
Akhurst, R. J. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.10.003 · Cited by 29 · see citing works
Li, M., Jia, D. T., Li, J., Li, Y., Wang, Y., Wang, Y., Xie, W., & Chen, S. (2024) · Inflammation · doi:10.1007/s10753-023-01947-7 · Cited by 28 · see citing works
Targeting the ILK/YAP axis by LFG-500 blocks epithelial–mesenchymal transition and metastasis
Li, C., Li, J., Gong, S., Huang, M., Li, R., Xiong, G., Wang, F., Zou, Q.-M., Qi, Q., & Yin, X. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00655-y · Cited by 28 · see citing works
Xia, Z., Qing, B., Wang, W., Gu, L., Chen, H., & Yuan, Y. (2021) · Thoracic Cancer · doi:10.1111/1759-7714.14217 · Cited by 28 · see citing works
Matricellular protein tenascin C: Implications in glioma progression, gliomagenesis, and treatment
Fu, Z., Zhu, G., Luo, C., Chen, Z., Dou, Z., Chen, Y., Chen, Z., Su, S., & Liu, F. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.971462 · Cited by 28 · see citing works
Wu, C., Zeng, M., Liao, G., Qian, K., & Li, H. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s275327 · Cited by 27 · see citing works
Li, Y., Li, Y., Luo, J., Fu, X., Liu, P., Liu, S., & Pan, Y. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01047-9 · Cited by 27 · see citing works
Resistance to mesenchymal reprogramming sustains clonal propagation in metastatic breast cancer
Saini, M., Schmidleitner, L., Moreno, H. D., Donato, E., Falcone, M., Bartsch, J. M., Klein, C., Vogel, V., Würth, R., Pfarr, N., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112533 · Cited by 25 · see citing works
HOXB5 promotes malignant progression in pancreatic cancer via the miR-6732 pathway
Li, Z., Wu, G., Jiang, W., Li, J., Wang, Y.-Y., Ju, X., & Yin, Y.-T. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1707456 · Cited by 25 · see citing works
How germline genes promote malignancy in cancer cells
Bruggeman, J. W., Köster, J., van Pelt, A. M. M., Speijer, D., & Hamer, G. (2022) · BioEssays · doi:10.1002/bies.202200112 · Cited by 25 · see citing works
Horny, K., Sproll, C. K., Peiffer, L., Furtmann, F., Gerhardt, P., Gravemeyer, J., Stoecklein, N. H., Spassova, I., & Becker, J. C. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04102-w · Cited by 25 · see citing works
PIEZO1 acts as a cancer suppressor by regulating the ROS / Wnt /β‐catenin axis
Bo, H., Wu, Q., Zhu, C., Zheng, Y., Cheng, G., & Cui, L. (2024) · Thoracic Cancer · doi:10.1111/1759-7714.15278 · Cited by 25 · see citing works
KLF4, Slug and EMT in Head and Neck Squamous Cell Carcinoma
Ingruber, J., Savic, D., Steinbichler, T. B., Sprung, S., Fleischer, F., Glueckert, R., Schweigl, G., Skvortsova, I., Riechelmann, H., & Dudás, J. (2021) · Cells · doi:10.3390/cells10030539 · Cited by 25 · see citing works
Crosstalk between lipid metabolism and EMT: emerging mechanisms and cancer therapy
Din, Z. U., Cui, B., Wang, C., Zhang, X., Mehmood, A., Peng, F., & Liu, Q. (2024) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-024-04995-1 · Cited by 24 · see citing works
Role of SPARC in the epithelial-mesenchymal transition induced by PTHrP in human colon cancer cells
Carriere, P., Calvo, N., Díaz, M. B. N., López‐Moncada, F., Herrera, A., Torres, M. J., Alonso, E. G., Gandini, N. A., Gigola, G., Contreras, H. R., et al. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111253 · Cited by 24 · see citing works
Bai, X., Li, Q., Peng, X., Li, X., Qiao, C., Tang, Y., & Zhao, R. (2023) · Purinergic Signalling · doi:10.1007/s11302-023-09928-z · Cited by 24 · see citing works
Epithelial to mesenchymal transition (EMT) in metaplastic breast cancer and phyllodes breast tumors
Ακρίδα, Ι., Mulita, F., Plachouri, K., Benetatos, N., Maroulis, I. C., & Papadaki, H. H. (2023) · Medical Oncology · doi:10.1007/s12032-023-02259-4 · Cited by 23 · see citing works
Ingruber, J., Dudás, J., Savic, D., Schweigl, G., Steinbichler, T. B., Greier, M. D. C., Santer, M., Carollo, S., Trajanoski, Z., & Riechelmann, H. (2022) · Experimental Cell Research · doi:10.1016/j.yexcr.2022.113084 · Cited by 23 · see citing works
Peindl, M., Göttlich, C., Crouch, S. A. W., Hoff, N., Lüttgens, T., Schmitt, F., Pereira, J. G. N., May, C., Schliermann, A., Kronenthaler, C., et al. (2022) · Cancers · doi:10.3390/cancers14092176 · Cited by 23 · see citing works
The Hallmarks of Cancer as Eco-Evolutionary Processes
Bhattacharya, R., Avdieiev, S. S., Bukkuri, A., Whelan, C. J., Gatenby, R. A., Tsai, K. Y., & Brown, J. S. (2025) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-0861 · Cited by 23 · see citing works
- Authors
- Derynck, R., & Weinberg, R. A.
- Affiliations
- University of California, San Francisco (US)
- Whitehead Institute for Biomedical Research (US)
- Corresponding author
- Derynck, Rik
- Weinberg, Robert A.
- Venue
- Developmental Cell
- Publisher
- Elsevier BV
- Published
- 2019-05
- Volume
- 49
- Issue
- 3
- Pages
- 313-316
- ISSN
- 1534-5807 (ISSN-L)
- PMC
- PMC7672963
- OpenAlex
- W2943895348
- Cited by
- 313
- References
- 16
- Citations by year
- 2026: 12 · 2025: 28 · 2024: 33 · 2023: 54 · 2022: 70 · 2021: 53 · 2020: 53 · 2019: 9
- FWCI
- 19.30
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Developmental Cell (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- NIH (RO1-CA136690, RO1-CA198179, P01 CA080111)
- Breast Cancer Research Foundation
- Samuel Waxman Cancer Research Foundation
- Breast Cancer Alliance
- Ludwig Center for Molecular Oncology
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- epithelial-mesenchymal transition, tumor progression, epithelial cells, fibrosis, wound healing, inflammation
- MeSH terms
- Animals, Cell Differentiation, Epithelial Cells, Humans, Neoplasms, Wound Healing, Signal Transduction, Epithelial-Mesenchymal Transition
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review